NCT04016051 - Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections | Biotech Hunter

Enrollment

265

Participants

Timeline

Start Date

September 22, 2004

Primary Completion Date

December 23, 2004

Study Completion Date

December 23, 2004

Conditions

Otitis MediaTonsillitisPharyngitisBronchitis

Interventions

DRUG

Clarithromycin DST (125 mg)

Clarithromycin DST (125.0 mg clarithromycin / straw).

DRUG

Clarithromycin DST (187.5 mg)

Clarithromycin DST (187.5 mg clarithromycin / straw).

DRUG

Clarithromycin DST (250 mg)

Clarithromycin DST (250.0 mg clarithromycin / straw).

DRUG

Clarithromycin Syrup (125 mg)

Clarithromycin Syrup 2.5 ml (125 mg).

DRUG

Clarithromycin Syrup (187.5 mg)

Clarithromycin Syrup 3.75 ml (187.5 mg).

DRUG

Clarithromycin Syrup (250 mg)

Clarithromycin Syrup 5 ml (250 mg).

Trial Locations (20)

30625

DE08, Hanover

31785

DE09, Hamelin

58802

DE11, Balve

59269

DE10, Beckum

80393

DE14, München

81241

DE05, München

81543

DE06, München

81669

DE03, München

81675

DE02, München

81739

DE13, München

82008

DE01, Unterhaching

82049

DE07, Pullach im Isartal

82140

DE04, Olching

94550

DE12, Künzing

Unknown

PL03, Koziegłowy

PL06, Krakow

PL01, LÓDZ

PL04, Otwock

PL05, Warsaw

PL02, Wroclaw